The IRBLleida, the University of Lleida and the University of Rovira i Virgili coordinated a study that promotes the participation of women in decision-making and strategies for early detection of breast cancer

Lleida, September 26, 2016 The Institute for Biomedical Research Foundation Dr. Pifarré (IRBLleida), the University of Lleida (UDL) and the University Rovira i Virgili lead a research study funding by the Instituto de Salud Carlos III who framed the customization of detection precoz cancer mama y de las mujeres in the participation in the decisions Related con su salud. The main Objective of study materials Informativos prepare reports (dípticos, website, Facebook page ...) Recoger that the current evidence of the beneficial and adverse efectos precoz detection of breast cancer, and to evaluate its effects on mujeres 48-51 years old, to those who fear being invited to participate in the programs first vez Detection precoz de Cataluña and Canarias. The justifications study is based on the results publicados in the últimos años (References 1, 2, 3) that are shown, the detection precoz breast cancer mediante mammography has beneficial, but also has efectos adverse that WOULD BE Reducir if personalizara the Frequency of mammographic examinations. The study reports a collaborative led by the IRBLleida Project, the University of Lleida and Rovira i Virgili University, with interests in the Institute Hospital del Mar Medical Research (IMIM), the Catalan Institute of Oncology, and the Canary Islands Health Service. The Project has a durations of three years and a financiación 68,450 euros. Currently is in the second year of desarrollo. Until now, it has Llevado to a cabo Qualitative research study, a systematic review should be initiated and a rehearsal population randomized and controlled. Ya empezado will have to edit them trípticos Informativos behind the meeting in Lleida, Barcelona and Canarias, and they just put in march a Facebook page: https://www.facebook.com/EstudioInforMa as well as on the label #estudioInforMaCM Twitter social platform like información de los resultados, publications and resources you go generando the study. The investigadoras the IRBLLEIDA and profesoras UdL Montserrat Rué and Montserrat Martínez-Alonso and Dr. Anna Pons, a specialist in Family Medicine, are the coordinadoras in Lleida, and equipped with the collaboration of the responsible Program Detection precoz in the Region health Lleida, Montse Llorens, the recruitment of para las mujeres in this area. Precisamente this month of September, they have to present empezado three conferences Communications Project: Ibero-American Conference on Qualitative Health Research (from 5 to 7 September, Barcelona); Annual Congress of the Spanish Society of Epidemiology (from 14 to 16 September, Sevilla); Preventing Overdiagnosis Conference (20 to 22 September, Barcelona). References: 1) Marmot MG, Altman DG, DA Cameron, Dewar JA, Thompson SG, M. Wilcox UK Independent Panel on Breast Cancer Screening. The Harms and benefits of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86. 2) Gøtzsche PC, Jørgensen KJ. Screening for Breast Cancer with Mammography. Cochrane Database Syst Rev 2013; (6): CD001877. 3) Vilaprinyó E, C Forné, Charles M, M Room, Level R, Castells X, L Domingo, rue M; Interval Cancer (INCA) Study Group. Cost-effectiveness and harm-benefit analysis of risk-based screening strategies for breast cancer. PlosOne 2014; 9: e86858.